Which of the following indicates a side effect of NNRTI medications?

Rash is indeed a well-known side effect associated with non-nucleoside reverse transcriptase inhibitors (NNRTIs). These medications, commonly used in the treatment of HIV, can cause cutaneous reactions in some patients, often presenting as a rash. This is particularly true for medications like efavirenz and nevirapine, where rashes can range from mild to severe. The occurrence of rash is significant enough that healthcare providers monitor patients starting NNRTI therapy closely for this adverse effect.

While osteoporosis, pancreatitis, and fatigue can relate to different medication classes or health conditions, they are not typically linked specifically to NNRTIs. It’s crucial for patients to be made aware of possible side effects, especially dermatological responses, as they may require adjustments to medication or additional interventions. Understanding this helps in the management and treatment plans for individuals receiving NNRTI therapy.